title: Efficacy and safety of the weight-loss drug rimonabant.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Després
authors.forename: Luc
authors.initials: L
authors.lastname: Van Gaal
authors.forename: Xavier
authors.initials: X
authors.lastname: Pi-Sunyer
authors.forename: André
authors.initials: A
authors.lastname: Scheen
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects*; D003863:Depression / Q000139:chemically induced; D003865:Major Depressive Disorder; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000523:psychology; D018579:Patient Selection; D010880:Piperidines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D000077285:Rimonabant; D013405:Suicide
chemical_list: D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant